Brief: Jubilant Pharmova Gets ANDA Approval For Doxepin Hydrochloride Capsules
March 17 (Reuters) - Jubilant Pharmova Ltd JUBA.NS :
* RECEIVES ANDA APPROVAL FOR DOXEPIN HYDROCHLORIDE CAPSULES
Source text for Eikon: ID:nBSE8yB0NM
Further company coverage: JUBA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jubilant Pharmova
See all newsBrief: Jubilant Pharmova Sept-Quarter Consol Net Profit 312 Million Rupees
Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802
India New Issue-Jubilant Pharmova to issue 3-year bonds, bankers say
India's Jubilant Pharmova eyes $150 mln through rupee debt sale, bankers say
Brief: Jubilant Pharmova To Consider Raising Of Funds Through Issuance Of Non- Convertible Debentures